Renal cell carcinoma echocardiography or ultrasound: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Revision as of 20:02, 27 August 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma echocardiography or ultrasound On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma echocardiography or ultrasound |
|
Renal cell carcinoma echocardiography or ultrasound in the news |
|
Blogs on Renal cell carcinoma echocardiography or ultrasound |
|
Risk calculators and risk factors for Renal cell carcinoma echocardiography or ultrasound |
Overview
Ultrasound (US) may be helpful when CT scan results are equivocal.
Ultrasound
Ultrasound (US) may be helpful when CT scan results are equivocal. It is noteworthy to mention that not all renal cell carcinomas are detectable on ultrasound.
| Patient Profile | Use of US | Evidence Strength |
| Low Risk Patient (pT1, N0, Nx) | US (or CT or MRI) may be performed in patients following radical nephrectomy if initial post-op baseline image is negative | C |
| Moderate to High Risk Patients (pT2-4N0 Nx or any stage N+) | Imaging, including US, may be used every 6 months (after a baseline chest and abdominal CT or MRI within 3-6 months following surgery) for at least 3 years and annually thereafter to 5 years. Site specific imaging is warranted by clinical symptoms suggestive of recurrence or metastatic spread. Imaging (US, CXR, CT, or MRI) beyond 5 years may be performed at the discretion of the clinician | C |
References
- ↑ Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.